Research published in the Journal of Clinical Psychiatry shows that of all 901 patients diagnosed with schizophrenia from July 2009 to June 2010 at a community mental health center, white patients were half as likely (OR = .52) than nonwhites to receive long-acting injectable antipsychotics, irrespective of age, gender or comorbid diagnoses including drug abuse. The authors speculate that prescribers may consider nonwhites to be less adherent to antipsychotic medications.
Related Items:
Psychosis May Be Overdiagnosed in Blacks
